http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SU-1720012-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6eff2d87414496b09bb38a7357dff005 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
| filingDate | 1990-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1992-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5795122268ea25b9b0e2eab4b66069c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a253fe2279c1180562d13e4ef78812fe http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c7180bb206f0fbfd0c40620cc49f74e |
| publicationDate | 1992-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | SU-1720012-A1 |
| titleOfInvention | Method for estimation of individual organism sensitivity to immune modulator |
| abstract | This invention relates to medicine and can be used to determine the individual sensitivity of an organism to immunomodulators. The purpose of the invention is to reduce the analysis time and g increase the accuracy of the method. Blood is collected from a patient, which is incubated in the presence of an immunomodulator, smears are prepared on the glass, one of which is incubated with acridine orange, the synthetic activity of the blood cells is determined in all smears and when it is increased by 20% and higher compared to the control The body's individual sensitivity to the immunomodulator is determined. Compared with the prototype, the analysis time is reduced by 48-60 times, and the accuracy is increased by 31.2-37.3%. |
| priorityDate | 1990-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 25.